Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes

Documenti analoghi

• Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
  di: Gros, Alena, et al.
  Pubblicazione: (2016)
• High frequency CD8+PD-1+ TCR clonotypes isolated from fresh melanomas display anti-tumor activity
  di: Anna, Pasetto, et al.
  Pubblicazione: (2015)
• Diversity of mutated antigen recognition by tumor infiltrating lymphocytes from patients with metastatic melanoma
  di: Crystal, Jessica S, et al.
  Pubblicazione: (2015)
• Use of CD137 up-regulation to identify T cell receptors specifically reactive with mutated tumor associated antigens from tumor infiltrating lymphocytes
  di: Parkhurst, Maria, et al.
  Pubblicazione: (2015)
• Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression
  di: Parkhurst, Maria, et al.
  Pubblicazione: (2016)